Signatures of epigenetic, biological and mitotic age acceleration and telomere shortening are associated with arsenic-induced skin lesions
Richie Jeremian,Yuliya Lytvyn,Rayyan Fotovati,Kaiyang Li,Muskaan Sachdeva,Nawar Tarafdar,Jorge R. Georgakopoulos,Vincent Piguet,Ivan V. Litvinov,Jensen Yeung
DOI: https://doi.org/10.1007/s00403-024-02923-3
2024-05-24
Archives of Dermatological Research
Abstract:Chronic arsenic exposure is a global health hazard significantly associated with the development of deleterious cutaneous changes and increased keratinocyte cancer risk. Although arsenic exposure is associated with broad-scale cellular and molecular changes, gaps exist in understanding how these changes impact the skin and facilitate malignant transformation. Recently developed epigenetic "clocks" can accurately predict chronological, biological and mitotic age, as well as telomere length, on the basis of tissue DNA methylation state. Deviations of predicted from expected age (epigenetic age dysregulation) have been associated with numerous complex diseases, increased all-cause mortality and higher cancer risk. We investigated the ability of these algorithms to detect molecular changes associated with chronic arsenic exposure in the context of associated skin lesions. To accomplish this, we utilized a multi-algorithmic approach incorporating seven "clocks" ( Horvath, Skin&Blood, PhenoAge, PCPhenoAge, GrimAge, DNAmTL and epiTOC2 ) to analyze peripheral blood of pediatric and adult cohorts of arsenic-exposed (n = 84) and arsenic-naïve (n = 33) individuals, among whom n = 18 were affected by skin lesions. Arsenic-exposed adults with skin lesions exhibited accelerated epigenetic ( Skin&Blood : + 7.0 years [95% CI 3.7; 10.2], q = 6.8 × 10 –4 ), biological ( PhenoAge: + 5.8 years [95% CI 0.7; 11.0], q = 7.4 × 10 –2 , p = 2.8 × 10 –2 ) and mitotic age ( epiTOC2: + 19.7 annual cell divisions [95% CI 1.8; 37.7], q = 7.4 × 10 –2 , p = 3.2 × 10 –2 ) compared to healthy arsenic-naïve individuals; and accelerated epigenetic age ( Skin&Blood: + 2.8 years [95% CI 0.2; 5.3], q = 2.4 × 10 –1 , p = 3.4 × 10 –2 ) compared to lesion-free arsenic-exposed individuals. Moreover, lesion-free exposed adults exhibited accelerated Skin&Blood age (+ 4.2 [95% CI 1.3; 7.1], q = 3.8 × 10 –2 ) compared to their arsenic-naïve counterparts. Compared to the pediatric group, arsenic-exposed adults exhibited accelerated epigenetic (+ 3.1 to 4.4 years (95% CI 1.2; 6.4], q = 2.4 × 10 –4 –3.1 × 10 –3 ), biological (+ 7.4 to 7.8 years [95% CI 3.0; 12.1] q = 1.6 × 10 –3 –2.8 × 10 –3 ) and mitotic age (+ 50.0 annual cell divisions [95% CI 15.6; 84.5], q = 7.8 × 10 –3 ), as well as shortened telomere length (− 0.23 kilobases [95% CI − 0.13; − 0.33], q = 2.4 × 10 –4 ), across all seven algorithms. We demonstrate that lifetime arsenic exposure and presence of arsenic-associated skin lesions are associated with accelerated epigenetic, biological and mitotic age, and shortened telomere length, reflecting altered immune signaling and genomic regulation. Our findings highlight the usefulness of DNA methylation-based algorithms in identifying deleterious molecular changes associated with chronic exposure to the heavy metal, serving as potential prognosticators of arsenic-induced cutaneous malignancy.
dermatology